209216-23-9
Product Name:
Entecavir hydrate
Formula:
C12H17N5O4
Synonyms:
2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
Inquiry
SAFETY INFORMATION
| Signal word | Danger |
|---|---|
| Pictogram(s) |
 Health Hazard GHS08 |
| GHS Hazard Statements |
H351:Carcinogenicity H372:Specific target organ toxicity, repeated exposure |
| Precautionary Statement Codes |
P201:Obtain special instructions before use. P202:Do not handle until all safety precautions have been read and understood. P260:Do not breathe dust/fume/gas/mist/vapours/spray. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P308+P313:IF exposed or concerned: Get medical advice/attention. |
PRODUCT INTRODUCTION
Description
Entecavir hydrate is the monohydrate form of entecavir, which is a nucleoside reverse transcriptase inhibitor. It is a synthetic analogue of 2'-deoxyguanosine, specifically designed to exhibit selective antiviral activity against the hepatitis B virus.